EU Approves First Biologic for Severe Uncontrolled Asthma

Tezspire is the first and only biologic approved in the EU for patients with severe asthma with no phenotype or biomarker limitations.
Medscape Medical News

source https://www.medscape.com/viewarticle/981382?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

Heart Failure Care Outside of ICU Can Lower Cost